Literature DB >> 82633

Characterization of sialytransferase in noncancerous and neoplastic human liver tissue.

H A Ingraham, J A Alhadeff.   

Abstract

When compared to uninvolved adjacent tissue, metastatic tumors in human liver appear to have significantly reduced sialytransferase activity. No significant kinetic differences (Michaelis constants, thermostability, and pH optima) between noncancerous and cancerous tissue sialytransferase were found. Mixing experiments between cancerous and noncancerous tissues indicated that inhibitors of sialytransferase activity were present in cancerous tissue. Subsequent experiments demonstrated increased levels of bound sialic acid in the tumor tissues. Inasmuch as futuin, a sialoglycoprotein, inhibits sialyltransferase activity, the increased levels of bound sialic acid in tumor tissue may be responsible for the reduced enzyme activity in these tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82633

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Post-operative serum sialyltransferase levels and prognosis in breast cancer.

Authors:  J Stewart; R Rubens; R Millis; J Hayward; S Hoare; R Bulbrook; D Kessel
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

2.  Presence of an atypical thermolabile species of beta-hexosaminidase B in metastatic-tumour tissue of human liver.

Authors:  J A Alhadeff; R T Holzinger
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

Review 3.  Serum-sialyltransferase activity in cancer patients.

Authors:  P G Berge; A Wilhelm; H Schriewer; G Wüst
Journal:  Klin Wochenschr       Date:  1982-05-03

4.  Sialyltransferase activity in tumor tissues.

Authors:  P G Berge; A Wilhelm; H Schriewer
Journal:  Klin Wochenschr       Date:  1984-04-02

5.  Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).

Authors:  S Matsuzaki; K Iwamura; M Itakura; T Katsunuma
Journal:  Gastroenterol Jpn       Date:  1980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.